BIIB029

· Bioverativ Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIIB029, covering 2015-06-18 to 2015-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B [Phase 3]

See pricing